609 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates female telogen effluvium: Randomized, double-blinded, placebo-controlled clinical trial

Journal article

Peer reviewed

M Bertolini, F Jimenez, E Lopez, M Alam, C Ward, J Chéret, G Westgate, F Rinaldi and R Paus

Journal of investigative dermatology, Vol.139(5), pp.S104-S104

2019-05-01

Metrics

8 Record Views

Title: 609 Topical Sandalore®, a specific OR2AT4-stimulating odorant, ameliorates female telogen effluvium: Randomized, double-blinded, placebo-controlled clinical trial
Creators: M Bertolini - Monasterium Laboratory, Skin and Hair Research Solutions, Muenster, Germany
F Jimenez - Mediteknia Clinic and Monasterium Clinical Hair Trial Unit, Gran Canaria, Spain
E Lopez - Mediteknia Clinic and Monasterium Clinical Hair Trial Unit, Gran Canaria, Spain
M Alam - Mediteknia Skin & Hair Lab, Gran Canaria, Spain
C Ward - Monasterium Laboratory, Skin and Hair Research Solutions, Muenster, Germany
J Chéret - University of Miami, Miami, Florida, United States
G Westgate - Gill Westgate Consultancy Ltd, Bedford, United Kingdom
F Rinaldi - Giuliani S.p.A., Milan, Italy
R Paus - University of Miami, Miami, Florida, United States
Publication Details: Journal of investigative dermatology, Vol.139(5), pp.S104-S104
Publisher: Elsevier Inc
Academic Unit: Miller School of Medicine; UMMG Dept of Dermatology & Cutaneous Surgery
Language: English
Resource Type: Journal article
Record Identifier: 991031598401502976